Software - Application
Compare Stocks
2 / 10Stock Comparison
NICE vs SPOK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
NICE vs SPOK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Medical - Healthcare Information Services |
| Market Cap | $7.72B | $225M |
| Revenue (TTM) | $2.95B | $103M |
| Net Income (TTM) | $613M | $11M |
| Gross Margin | 66.4% | 91.4% |
| Operating Margin | 21.9% | 13.2% |
| Forward P/E | 11.4x | 16.5x |
| Total Debt | $164M | $7M |
| Cash & Equiv. | $379M | $25M |
NICE vs SPOK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| NICE Ltd. (NICE) | 100 | 52.0 | -48.0% |
| Spok Holdings, Inc. (SPOK) | 100 | 104.1 | +4.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NICE vs SPOK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NICE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 8.5%, EPS growth 44.2%, 3Y rev CAGR 10.8%
- 96.6% 10Y total return vs SPOK's 13.1%
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
SPOK is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 5 yrs, beta 0.42, yield 11.9%
- Beta 0.42, yield 11.9%, current ratio 1.18x
- Beta 0.42 vs NICE's 0.72
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.5% revenue growth vs SPOK's 1.5% | |
| Value | Lower P/E (11.4x vs 16.5x) | |
| Quality / Margins | 20.8% margin vs SPOK's 10.3% | |
| Stability / Safety | Beta 0.42 vs NICE's 0.72 | |
| Dividends | 11.9% yield; 5-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -20.9% vs SPOK's -26.3% | |
| Efficiency (ROA) | 12.0% ROA vs SPOK's 5.2%, ROIC 13.5% vs 11.3% |
NICE vs SPOK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NICE vs SPOK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $3.0B annually — 28.5x SPOK's $103M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to SPOK's 10.3%. On growth, NICE holds the edge at +9.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $3.0B | $103M |
| EBITDAEarnings before interest/tax | $846M | $17M |
| Net IncomeAfter-tax profit | $613M | $11M |
| Free Cash FlowCash after capex | $665M | $26M |
| Gross MarginGross profit ÷ Revenue | +66.4% | +91.4% |
| Operating MarginEBIT ÷ Revenue | +21.9% | +13.2% |
| Net MarginNet income ÷ Revenue | +20.8% | +10.3% |
| FCF MarginFCF ÷ Revenue | +22.5% | +24.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.7% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +57.8% | -64.0% |
Valuation Metrics
Evenly matched — NICE and SPOK each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 12.8x trailing earnings, NICE trades at a 12% valuation discount to SPOK's 14.5x P/E. On an enterprise value basis, NICE's 8.7x EV/EBITDA is more attractive than SPOK's 8.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $7.7B | $225M |
| Enterprise ValueMkt cap + debt − cash | $7.5B | $207M |
| Trailing P/EPrice ÷ TTM EPS | 12.82x | 14.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.42x | 16.47x |
| PEG RatioP/E ÷ EPS growth rate | 0.48x | — |
| EV / EBITDAEnterprise value multiple | 8.72x | 8.95x |
| Price / SalesMarket cap ÷ Revenue | 2.60x | 1.61x |
| Price / BookPrice ÷ Book value/share | 2.04x | 1.56x |
| Price / FCFMarket cap ÷ FCF | 10.98x | 8.94x |
Profitability & Efficiency
NICE leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
NICE delivers a 15.8% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for SPOK. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to SPOK's 0.05x. On the Piotroski fundamental quality scale (0–9), NICE scores 7/9 vs SPOK's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +15.8% | +7.3% |
| ROA (TTM)Return on assets | +12.0% | +5.2% |
| ROICReturn on invested capital | +13.5% | +11.3% |
| ROCEReturn on capital employed | +16.4% | +12.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.04x | 0.05x |
| Net DebtTotal debt minus cash | -$216M | -$18M |
| Cash & Equiv.Liquid assets | $379M | $25M |
| Total DebtShort + long-term debt | $164M | $7M |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (Dividends Reinvested)
Evenly matched — NICE and SPOK each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SPOK five years ago would be worth $16,329 today (with dividends reinvested), compared to $5,301 for NICE. Over the past 12 months, NICE leads with a -20.9% total return vs SPOK's -26.3%. The 3-year compound annual growth rate (CAGR) favors SPOK at 4.3% vs NICE's -12.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +11.7% | -14.0% |
| 1-Year ReturnPast 12 months | -20.9% | -26.3% |
| 3-Year ReturnCumulative with dividends | -33.2% | +13.4% |
| 5-Year ReturnCumulative with dividends | -47.0% | +63.3% |
| 10-Year ReturnCumulative with dividends | +96.6% | +13.1% |
| CAGR (3Y)Annualised 3-year return | -12.6% | +4.3% |
Risk & Volatility
Evenly matched — NICE and SPOK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SPOK is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than NICE's 0.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NICE currently trades 69.2% from its 52-week high vs SPOK's 56.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.72x | 0.42x |
| 52-Week HighHighest price in past year | $180.61 | $19.31 |
| 52-Week LowLowest price in past year | $94.89 | $9.96 |
| % of 52W HighCurrent price vs 52-week peak | +69.2% | +56.3% |
| RSI (14)Momentum oscillator 0–100 | 70.6 | 38.8 |
| Avg Volume (50D)Average daily shares traded | 588K | 185K |
Analyst Outlook
SPOK leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates NICE as "Buy" and SPOK as "Hold". Consensus price targets imply 38.0% upside for SPOK (target: $15) vs 20.7% for NICE (target: $151). SPOK is the only dividend payer here at 11.90% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $150.88 | $15.00 |
| # AnalystsCovering analysts | 23 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +11.9% |
| Dividend StreakConsecutive years of raises | 0 | 5 |
| Dividend / ShareAnnual DPS | — | $1.29 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.4% | +1.3% |
NICE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SPOK leads in 1 (Analyst Outlook). 3 tied.
NICE vs SPOK: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NICE or SPOK a better buy right now?
For growth investors, NICE Ltd.
(NICE) is the stronger pick with 8. 5% revenue growth year-over-year, versus 1. 5% for Spok Holdings, Inc. (SPOK). NICE Ltd. (NICE) offers the better valuation at 12. 8x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate NICE Ltd. (NICE) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NICE or SPOK?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 12. 8x versus Spok Holdings, Inc. at 14. 5x. On forward P/E, NICE Ltd. is actually cheaper at 11. 4x.
03Which is the better long-term investment — NICE or SPOK?
Over the past 5 years, Spok Holdings, Inc.
(SPOK) delivered a total return of +63. 3%, compared to -47. 0% for NICE Ltd. (NICE). Over 10 years, the gap is even starker: NICE returned +96. 6% versus SPOK's +13. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NICE or SPOK?
By beta (market sensitivity over 5 years), Spok Holdings, Inc.
(SPOK) is the lower-risk stock at 0. 42β versus NICE Ltd. 's 0. 72β — meaning NICE is approximately 73% more volatile than SPOK relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 5% for Spok Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NICE or SPOK?
By revenue growth (latest reported year), NICE Ltd.
(NICE) is pulling ahead at 8. 5% versus 1. 5% for Spok Holdings, Inc. (SPOK). On earnings-per-share growth, the picture is similar: NICE Ltd. grew EPS 44. 2% year-over-year, compared to 2. 7% for Spok Holdings, Inc.. Over a 3-year CAGR, NICE leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NICE or SPOK?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus 11. 4% for Spok Holdings, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 22. 2% versus 14. 1% for SPOK. At the gross margin level — before operating expenses — SPOK leads at 78. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NICE or SPOK more undervalued right now?
On forward earnings alone, NICE Ltd.
(NICE) trades at 11. 4x forward P/E versus 16. 5x for Spok Holdings, Inc. — 5. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SPOK: 38. 0% to $15. 00.
08Which pays a better dividend — NICE or SPOK?
In this comparison, SPOK (11.
9% yield) pays a dividend. NICE does not pay a meaningful dividend and should not be held primarily for income.
09Is NICE or SPOK better for a retirement portfolio?
For long-horizon retirement investors, Spok Holdings, Inc.
(SPOK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 11. 9% yield). Both have compounded well over 10 years (SPOK: +13. 1%, NICE: +96. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NICE and SPOK?
These companies operate in different sectors (NICE (Technology) and SPOK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
SPOK pays a dividend while NICE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.